These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33801565)

  • 1. Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study.
    Santos García D; Labandeira Guerra C; Yáñez Baña R; Cimas Hernando MI; Cabo López I; Paz Gonález JM; Alonso Losada MG; González Palmás MJ; Martínez Miró C
    Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33801565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Safinamide over Mood in Parkinson's Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR.
    Labandeira CM; Alonso Losada MG; Yáñez Baña R; Cimas Hernando MI; Cabo López I; Paz González JM; Gonzalez Palmás MJ; Martínez Miró C; Santos García D
    Adv Ther; 2021 Oct; 38(10):5398-5411. PubMed ID: 34523075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study.
    Santos García D; Fernández Pajarín G; Oropesa-Ruiz JM; Escamilla Sevilla F; Rahim López RRA; Muñoz Enríquez JG
    Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain Improvement in Parkinson's Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study.
    Santos García D; Yáñez Baña R; Labandeira Guerra C; Cimas Hernando MI; Cabo López I; Paz González JM; Alonso Losada MG; Gonzalez Palmás MJ; Cores Bartolomé C; Martínez Miró C
    J Pers Med; 2021 Aug; 11(8):. PubMed ID: 34442442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safinamide improves sleep and daytime sleepiness in Parkinson's disease: results from the SAFINONMOTOR study.
    Santos García D; Cabo López I; Labandeira Guerra C; Yáñez Baña R; Cimas Hernando MI; Paz González JM; Alonso Losada MG; Gonzalez Palmás MJ; Cores Bartolomé C; Martínez Miró C
    Neurol Sci; 2022 Apr; 43(4):2537-2544. PubMed ID: 34554335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of safinamide on pain in patients with fluctuating Parkinson's disease.
    Grigoriou S; Martínez-Martín P; Ray Chaudhuri K; Rukavina K; Leta V; Hausbrand D; Falkenburger B; Odin P; Reichmann H
    Brain Behav; 2021 Oct; 11(10):e2336. PubMed ID: 34478245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-motor symptoms burden in motor-fluctuating patients with Parkinson's disease may be alleviated by safinamide: the VALE-SAFI study.
    De Masi C; Liguori C; Spanetta M; Fernandes M; Cerroni R; Garasto E; Pierantozzi M; Mercuri NB; Stefani A
    J Neural Transm (Vienna); 2022 Nov; 129(11):1331-1338. PubMed ID: 36070008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study.
    Prakash KM; Nadkarni NV; Lye WK; Yong MH; Tan EK
    Eur J Neurol; 2016 May; 23(5):854-60. PubMed ID: 26806538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of non-motor symptoms on the Health-Related Quality of Life of Parkinson's disease patients from Southwest China.
    Song W; Guo X; Chen K; Chen X; Cao B; Wei Q; Huang R; Zhao B; Wu Y; Shang HF
    Parkinsonism Relat Disord; 2014 Feb; 20(2):149-52. PubMed ID: 24161377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Safinamide on Patient-Reported Outcomes in Parkinson's Disease.
    Espinoza-Vinces C; Villino-Rodríguez R; Atorrasagasti-Villar A; Martí-Andrés G; Luquin MR
    Patient Relat Outcome Meas; 2023; 14():285-295. PubMed ID: 37840836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.
    Antonini A; Bauer L; Dohin E; Oertel WH; Rascol O; Reichmann H; Schmid M; Singh P; Tolosa E; Chaudhuri KR
    Eur J Neurol; 2015 Oct; 22(10):1400-7. PubMed ID: 26095948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non motor symptoms in progressive supranuclear palsy: prevalence and severity.
    Radicati FG; Martinez Martin P; Fossati C; Chaudhuri KR; Torti M; Rodriguez Blazquez C; Vacca L; Stocchi F
    NPJ Parkinsons Dis; 2017; 3():35. PubMed ID: 29238748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease.
    Rizzone MG; Mancini F; Artusi CA; Balestrino R; Bonvegna S; Fabbri M; Imbalzano G; Montanaro E; Romagnolo A; Zibetti M; Lopiano L
    Neurol Sci; 2022 May; 43(5):3187-3193. PubMed ID: 34982297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evolution of non-motor symptoms in early Parkinson's disease: a 3-year prospective cohort study.
    Ou R; Hou Y; Wei Q; Lin J; Liu K; Zhang L; Jiang Z; Cao B; Zhao B; Song W; Shang H
    NPJ Parkinsons Dis; 2021 Jul; 7(1):58. PubMed ID: 34267217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson's disease patients: a prospective longitudinal study.
    De Micco R; Satolli S; Siciliano M; De Mase A; Giordano A; Tedeschi G; Tessitore A
    Neurol Sci; 2022 Jan; 43(1):357-364. PubMed ID: 34031800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson's disease.
    Bianchi MLE; Riboldazzi G; Mauri M; Versino M
    Neurol Sci; 2019 Feb; 40(2):275-279. PubMed ID: 30382437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender and onset age related-differences of non-motor symptoms and quality of life in drug-naïve Parkinson's disease.
    Hu T; Ou R; Liu H; Hou Y; Wei Q; Song W; Cao B; Chen Y; Yuan X; Shang H
    Clin Neurol Neurosurg; 2018 Dec; 175():124-129. PubMed ID: 30408646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue in fluctuating Parkinson's disease patients: possible impact of safinamide.
    Pauletti C; Locuratolo N; Mannarelli D; Maffucci A; Petritis A; Menini E; Fattapposta F
    J Neural Transm (Vienna); 2023 Jul; 130(7):915-923. PubMed ID: 37210459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.